Table 1.
Demographics between patients with sarcopenia and without sarcopenia
| Characteristics | Sarcopenia | Non-sarcopenia | p-value |
|---|---|---|---|
| Patients (number) | 112 (67.1%) | 55 (32.9%) | |
| Age (years)a | 63.1 ± 11.6 | 60.5 ± 11.5 | 0.152 |
| Gender, n | < 0.001 | ||
| Male | 90(53.9%) | 28(16.8%) | |
| Female | 22(13.2%) | 27(16.2%) | |
| Weight (kg)a | 57.2 ± 9.8 | 63.5 ± 9.3 | < 0.001 |
| Height (m)a | 1.64 ± 0.08 | 1.62 ± 0.08 | 0.028 |
| Body mass index, (kg/m2)a | 21.1 ± 3.2 | 24.3 ± 3.1 | < 0.001 |
| Laboratory results | |||
| Creatinine, mg/dL | 3.6 ± 1.10 | 3.3 ± 0.71 | 0.157 |
| HbA1c, % Fasting glucose level, mg/dL |
7.6 ± 0.7 158.2 ± 23.3 |
7.6 ± 0.73 161.4 ± 25.8 |
0.851 0.421 |
| Comorbidity | |||
| Hypertension (yes/no) | 36(32.1%) / 76(67.9%) | 18(32.7%) / 37(67.3%) | 0.981 |
| Cardiac disease (yes/no) | 27(24.1%) / 85(75.9%) | 0.498 | |
| Pulmonary disease (yes/no) | 10(8.9%) / 102(91.1%) | 10(18.2%) / 45(81.8%) | 0.514 |
| Cerebrovascular disease (yes/no) | 12(10.7%) / 100(89.3%) | 7(12.7%) / 48(87.3%) | 0.574 |
| Renal disease (yes/no) | 52(46.4%) / 60(53.6%) | 4(7.3%) / 51(92.7%) 24(43.6%) / 31(56.4%) | 0.582 |
| Level of LEA | |||
| Minor LEA (number) | 78(69.6%) | 46(83.6%) | |
| Toe | 29 | 11 | |
| Ray | 27 | 25 | |
| Transmetatarsal | 22 | 10 | |
| Major LEA (number) | 34(30.4%) | 9(16.4%) | |
| Below knee | 29 | 8 | |
| Above knee | 5 | 1 | |
aData are present as Mean ± SD [range], LEA: Lower extremity amputation